Nordic Bone expects to start clinical trials this year  

2004.02.26
The Copenhagen based fledgling firm aims to start clinical trials of its first drug for the treatment of osteoporosis at the end of 2004

Biotech company Nordic Bone aims to start clinical trials of its first drug for the treatment of osteoporosis before the end of 2004, only 14 months after the company was established. Stephan Christgau, managing director of Nordic Bone, says the reason why the development time is so fast is because Nordic Bone develops a drug which is structurally related to a well-known drug that has completed phase III trials with fine results. Nordic Bone is expecting its first drug registration in 2008/2009.

 

Nordic Bone plans to employ more people towards the end of the year when the clinical trials start. Nordic Bone is located in Symbion Science Park, Copenhagen. The news is reported by BiotechDenmark online.

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×